Nursing Community News

Search news generated by local and national nursing associations

Narcan (naloxone) Nasal Spray Approved by FDA

Kansas City, MO
The Greater Kansas City Chapter of ASPMN

New Drug Approval

Sent to subscribers of: Opioid Overdose

FDA Approves Narcan (naloxone) Nasal Spray to Treat Opioid Overdose

November 18, 2015
Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose. Read More here